52%Aspartate aminotransferase increased
33%Palmar-plantar erythrodysesthesia syndrome
29%Alanine aminotransferase increased
24%Musculoskeletal and connective tissue disorder - Other, specify
19%Skin and subcutaneous tissue disorders - Other, specify
19%Serum amylase increased
14%Eye disorders - Other, specify
14%Blood and lymphatic system disorders - Other, specify
10%Platelet count decreased
10%Investigations - Other, specify
10%Generalized muscle weakness
10%Peripheral sensory neuropathy
10%Gastrointestinal disorders - Other, specify
10%General disorders and administration site conditions - Other, specify
10%Muscle weakness lower limb
10%Ejection fraction decreased
10%Gastroesophageal reflux disease
5%Vascular disorders - Other, specify
5%Injury, poisoning and procedural complications - Other, specify
5%Blood bilirubin increased
5%Muscle weakness upper limb
5%Nervous system disorders - Other, specify
5%Upper respiratory infection
5%Activated partial thromboplastin time prolonged
5%Urinary tract infection